A Breakthrough in Vision Preservation
In an exciting breakthrough announced in December 2017, scientists at Augusta University discovered that a common pain medication can help preserve vision in a model of severe, blinding retinal degeneration — and the mechanism involves activating one of the most powerful antioxidant systems in the human body: NRF2.
"We are very, very pleased that we can now explore the mechanisms," said Dr. Sylvia Smith, chair of the Department of Cellular Biology and Anatomy at the Medical College of Georgia at Augusta University and co-director of the James and Jean Culver Vision Discovery Institute.
The Sigma 1 Receptor and NRF2 Connection
The drug at the center of this discovery is pentazocine, which activates the Sigma 1 receptor — a unique protein that acts as a powerful natural antioxidant regulator and NRF2 activator. When pentazocine binds to the Sigma 1 receptor, it triggers a cascade that ultimately activates NRF2 and its downstream protective genes.
A new $1.14 million grant from the National Eye Institute (part of the NIH) is enabling the Augusta University team to explore how this NRF2-protecting ability can be harnessed against sight-degrading conditions including:
- Retinitis pigmentosa — A genetic condition causing progressive retinal degeneration
- Age-related macular degeneration (AMD) — The leading cause of vision loss in people over 60
- Glaucoma — The second leading cause of blindness worldwide
Why the Retina Is Especially Vulnerable to Oxidative Stress
The retina is one of the most metabolically active tissues in the body, and several factors make it uniquely susceptible to oxidative damage:
- Constant light exposure — Photo-oxidation generates free radicals continuously
- High oxygen consumption — The retina consumes more oxygen per gram than any other tissue
- Polyunsaturated fatty acid (PUFA) concentration — Photoreceptor membranes are rich in DHA, making them vulnerable to lipid peroxidation
- Phagocytosis of shed photoreceptor segments — Generates oxidative byproducts in RPE cells
This perfect storm of oxidative vulnerability makes NRF2 activation a particularly logical therapeutic strategy for retinal diseases.
NRF2's Protective Role in the Eye
Research has shown that NRF2 protects retinal cells through multiple mechanisms:
- Upregulating glutathione synthesis — the retina's primary antioxidant defense
- Inducing heme oxygenase-1 (HO-1) in retinal pigment epithelial (RPE) cells
- Reducing inflammation in retinal blood vessels
- Protecting mitochondrial function in photoreceptors
- Preventing light-induced photoreceptor apoptosis
Dietary Support for Eye Health Through NRF2
While the Augusta University research focuses on pharmaceutical activation, dietary NRF2 support may complement eye health:
- Broccoli sprouts — Sulforaphane has shown retinal protective effects in preclinical studies
- Blueberries — Anthocyanins activate NRF2 and support retinal health
- Salmon and omega-3 rich fish — DHA is essential for photoreceptor membranes and supports NRF2
- Spinach and leafy greens — Lutein and zeaxanthin combined with NRF2 activation provide dual retinal protection
References
- Smith SB, et al. Augusta University / Medical College of Georgia. National Eye Institute Grant, December 2017.
- Nrf2 activation via Sigma 1 receptor in retinal degeneration models. James and Jean Culver Vision Discovery Institute at AU.